BETR.CN Stock - BetterLife Pharma Inc.
Unlock GoAI Insights for BETR.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | $-18,435 | $-18,436 | $-22.808 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-5,000,113 | $-3,240,241 | $-9,460,653 | $-10,207,825 | $-7,915,367 |
| Net Income | $-3,520,288 | $-2,889,032 | $-9,016,201 | $-12,159,174 | $-36,350,790 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.03 | $-0.03 | $-0.10 | $-0.16 | $-1.34 |
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity. It is also developing MM-003 for treatment of COVID-19 and other respiratory viral infections; MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and AP-002 for the treatment of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
Visit WebsiteEarnings History & Surprises
BETR.CNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 27, 2026 | — | — | — | — |
Q4 2025 | Dec 29, 2025 | — | — | — | — |
Q3 2025 | Sep 23, 2025 | — | $-0.00 | — | — |
Q2 2025 | Jun 25, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 30, 2024 | — | — | — | — |
Q4 2024 | Dec 27, 2024 | — | — | — | — |
Q3 2024 | Sep 25, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 27, 2024 | — | $-0.02 | — | — |
Q1 2024 | Jan 2, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 29, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 27, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 28, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 22, 2022 | — | $-0.05 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 30, 2022 | — | $-0.04 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.05 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-0.03 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.05 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.04 | — | — |
Latest News
Frequently Asked Questions about BETR.CN
What is BETR.CN's current stock price?
What is the analyst price target for BETR.CN?
What sector is BetterLife Pharma Inc. in?
What is BETR.CN's market cap?
Does BETR.CN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BETR.CN for comparison